Literature DB >> 24634930

Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.

Hidetoshi Nitta, Shigeki Okamura, Takao Mizumoto, Hiroo Matsushita, Takumasa Nishimura, Yasuhiro Shimokawa, Masami Kimura, Hideo Baba.   

Abstract

BACKGROUND/AIMS: We investigated the postoperative outcome and risk factors for DIC and mortality in cases of implanted PVS.
METHODOLOGY: We reviewed the cases of 65 patients implanted with PVS from 2000 to 2010. Of these patients, 32 were diagnosed with peritonitis carcinomatosa, 21 had liver cirrhosis with hepatocellular carcinoma (HCC), and 12 had liver cirrhosis without HCC.
RESULTS: The postoperative morbidity rate was 18.8%, 76.2%, and 58.3% in cases of peritonitis carcinomatosa, liver cirrhosis with HCC, and liver cirrhosis without HCC, respectively. Early death (within 7 days of surgery) was 7.7% (5/65), and the cause of death in all cases was DIC. Underlying disease, low platelet count, prolongation of prothrombin time (PT), and hyperbilirubinemia were the risk factors for development of DIC, whereas underlying disease, prolongation of PT, hypoalbuminemia, and hyperbilirubinemia were risk factors for early death. Multivariate analysis showed that liver cirrhosis with HCC and prolonged PT were the risk factors for DIC.
CONCLUSIONS: Patients with refractory ascites due to liver cirrhosis with HCC and those with prolonged PT should not be considered for PVS.

Entities:  

Mesh:

Year:  2013        PMID: 24634930

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report.

Authors:  Kota Shigeto; Takumi Kawaguchi; Takashi Niizeki; Yasushi Kunitake; Hidetoshi Takedatsu; Tatsuyuki Tonan; Kiminori Fujimoto; Masatoshi Tanaka; Toshi Abe; Hisanori Naito; Takuji Torimura
Journal:  Oncol Lett       Date:  2016-03-21       Impact factor: 2.967

2.  Automated low flow pump system for the treatment of refractory ascites: a single-center experience.

Authors:  M N Thomas; G H Sauter; A L Gerbes; M Stangl; T S Schiergens; M Angele; J Werner; M Guba
Journal:  Langenbecks Arch Surg       Date:  2015-11-13       Impact factor: 3.445

3.  Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites.

Authors:  D Hariharan; E A Wilkes; G P Aithal; S J Travis; D N Lobo
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.